Insulet Corporation (GOV F) stock market data APIs
€211.4437
1.2(0.6%)
as of February 4, 2026
Try our APIs with
free plan!
Insulet Corporation Financial Data Overview
Price chart is built with
Anychart
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Prev. Close
211.4437
Open
212.3665
High
216.177
Low
211.1702
52 wk Range
205.1-304
Market Cap
14 857 M
P/E Ratio
72.8276
Shares Outstanding
70 347 K
Revenue
2 522 M
EPS
-0.37
Beta
1.418
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Insulet Corporation data using free add-ons & libraries
Get Insulet Corporation Fundamental Data
Insulet Corporation Fundamental data includes:
- Net Revenue: 2 522 M
- EBITDA: 511 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-08-05
- EPS/Forecast: 0.13
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Insulet Corporation News
New
Insulet Corporation (PODD): A Bull Case Theory
We came across a bullish thesis on Insulet Corporation on The Wealth Dynasty Report’s Substack. In this article, we will summarize the bulls’ thesis on PODD. Insulet Corporation's share was tradi...
2 S&P 500 Stocks to Research Further and 1 Facing Challenges
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headw...
Reasons Why Hedge Funds Favor Insulet Corp (PODD)
Insulet Corporation (NASDAQ:PODD) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. As of the close of play on January 28, Insulet Corporation (NASDAQ:PODD) carried ...
Assessing Insulet (PODD) Valuation After Recent Share Price Weakness And Growth Expectations
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Insulet (PODD) is back on investors’ radar after recent trading pressure, with the share ...
Get Insulet Corporation fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
